Education
About Us
Working with TipRanks
Follow Us
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
TVGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.26 - $3.09
Previous CloseN/A
Volume2.03M
Average Volume (3M)1.16M
Market Cap
$165.65M
Enterprise Value$246.05M
Total Cash (Recent Filing)$685.23K
Total Debt (Recent Filing)$7.56M
Price to Earnings (P/E)―
Beta0.02
Next Earnings
Nov 25, 2025EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding196,705,060
10 Day Avg. Volume567,728
30 Day Avg. Volume1,159,238
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.49
Enterprise Value/Revenue620.43
Enterprise Value/Gross Profit-821.18
Enterprise Value/Ebitda-8.00
Forecast
1Y Price Target
$10.00Price Target Upside1090.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Tevogen Bio Holdings News
TVGN FAQ
What was Tevogen Bio Holdings’s price range in the past 12 months?
Tevogen Bio Holdings lowest stock price was $0.26 and its highest was $3.09 in the past 12 months.
What is Tevogen Bio Holdings’s market cap?
Tevogen Bio Holdings’s market cap is $165.65M.
When is Tevogen Bio Holdings’s upcoming earnings report date?
Tevogen Bio Holdings’s upcoming earnings report date is Nov 25, 2025 which is in 67 days.
How were Tevogen Bio Holdings’s earnings last quarter?
Tevogen Bio Holdings released its earnings results on Aug 14, 2025. The company reported -$0.031 earnings per share for the quarter, beating the consensus estimate of -$0.05 by $0.019.
Is Tevogen Bio Holdings overvalued?
According to Wall Street analysts Tevogen Bio Holdings’s price is currently Undervalued.
Does Tevogen Bio Holdings pay dividends?
Tevogen Bio Holdings does not currently pay dividends.
What is Tevogen Bio Holdings’s EPS estimate?
Tevogen Bio Holdings’s EPS estimate is -0.06.
How many shares outstanding does Tevogen Bio Holdings have?
Tevogen Bio Holdings has 196,705,060 shares outstanding.
What happened to Tevogen Bio Holdings’s price movement after its last earnings report?
Tevogen Bio Holdings reported an EPS of -$0.031 in its last earnings report, beating expectations of -$0.05. Following the earnings report the stock price went down -2.97%.
Which hedge fund is a major shareholder of Tevogen Bio Holdings?
Among the largest hedge funds holding Tevogen Bio Holdings’s share is Saba Capital Management. It holds Tevogen Bio Holdings’s shares valued at 0.
Tevogen Bio Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (1090.48% Upside)
$10.00 (1090.48% Upside)
Hedge Fund Trend
Decreased
By 5.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
85.99%
12-Months-Change
Fundamentals
Return on Equity
-124.74%
Trailing 12-Months
Asset Growth
28.97%
Trailing 12-Months
Company Description
Tevogen Bio Holdings
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Technical Analysis
Codexis
―
Cidara Therapeutics
―
Corvus Pharmaceuticals
―
Nuvectis Pharma
―
CARGO Therapeutics, Inc.
―
Ownership Overview
73.20% Insiders
0.83% Mutual Funds
0.06% Other Institutional Investors
24.74% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---